StayCurrentMD · Lymphatic malformations compromising the upper airway in children: ultrasound-guided intralesional focal sclerotherapy with bleomycin targeting culprit lesions
Article1 min read·Published Jul 2020Older

Lymphatic malformations compromising the upper airway in children: ultrasound-guided intralesional focal sclerotherapy with bleomycin targeting culprit lesions

link.springer.com shows its articles on its own site.

Read the article on link.springer.com ↗

Article · Jul 2020 · 1 min read

In brief

In brief

This study presents a targeted ultrasound-guided bleomycin sclerotherapy technique for pediatric lymphatic malformations causing upper airway compromise. The focal approach achieved rapid lesion shrinkage with low bleomycin doses, enabling airway support withdrawal in a median of 15 days and avoiding tracheostomy in all 11 patients without complications.

Written by the GCMD Library team from the article.

Abstract

Purpose

Lymphatic malformations (LMs) compromising the upper airway is a life-threatening and intractable disease. Here, we establish a novel method to perform intralesional focal sclerotherapy targeting the culprit for airway stenosis.

Methods

Between July 2015 and February 2020, 11 patients with airway-compromising LMs were enrolled. To yield maximal effects on the compromised airway with minimal adverse effects, ultrasound-guided intralesional bleomycin sclerotherapy assisted by balloon was performed, aimed at the most responsible lesion around the airway. A retrospective analysis was performed.

Results

Ten patients presented with respiratory symptoms, eight of whom required airway support. The last asymptomatic patient showed airway compression on magnetic resonance imaging. The dose of bleomycin injected ranged from 1.3–9 mg per patient per course. A median of one course was required for withdrawal from airway support, and the median time was 15 days. A median of two courses was required to eliminate the lesion adjacent to the airway, which would have potential risk of airway stenosis. No complications were observed.

Conclusions

Our intralesional focal sclerotherapy technique with bleomycin targeting the culprit lesion is dose-sparing, safe, and effective in achieving rapid shrinkage of LMs compromising the upper airway in children, thereby avoiding tracheostomy.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →